{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:15:39Z","timestamp":1784250939842,"version":"3.55.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Increasing evidence shows that hyperglycemia-induced glucotoxicity and lipotoxicity that usually accompany diabetes development damage the endoplasmic reticulum and mitochondria of the hepatocytes in diabetic patients. Clinical studies highlighted the association between type 2 diabetes mellitus, comorbidities, and medications with liver function. The objective of this study is to explore the association between liver function tests\u2019 abnormalities and comorbidities, medications, and other risk factors in type 2 diabetes patients registered in the Best-Care system of the Saudi Ministry of National Guard-Health Affairs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a cross-sectional study employing a chart of patients diagnosed with type 2 diabetes mellitus. We drew a simple random sample of 523 T2DM patients who had a liver function test from the Best-Care database of the Ministry. We applied various statistical analyses, including Student\u2019s independent t-test, Pearson\u2019s chi-squared test, Fisher\u2019s exact test, and odd ratios, to measure associations between different variables and liver function tests\u2019 abnormalities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>About 35% of patients included in this study showed an abnormal level of gamma-glutamyl transferase and prothrombin time. Abnormalities of serum albumin, prothrombin time, and total serum protein tests were significantly associated with age (P &amp;lt; 0.05). Gamma-glutamyl transferase test abnormalities were significantly associated with gender (P &amp;lt; 0.05). The study found associations between several comorbidities and the abnormalities of liver function tests. These tests include the total bilirubin, albumin, total serum protein, gamma-glutamyl trans, international normalized ratio, and alanine aminotransferase. The associations were at significant levels (P &amp;lt; 0.05). Liraglutide was significantly associated with aspartate aminotransferase (OR = 14.40, 95% CI = 2.8, 73.2), while allopurinol was significantly associated with international normalized ratios (OR = 24.67, 95% CI = 2.95, 206.58) and total serum protein (OR = 5.44, 95% CI = 1.43, 20.83).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study is the first to examine the association between type 2 diabetes mellitus and liver function tests\u2019 abnormalities in Saudi Arabia. Although the results have a limited generalizability due to inherent biases, the findings align with similar studies in other populations. The study stresses the need to monitor liver functions, especially of T2DM patients who suffer from other conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcdhc.2025.1617641","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:10:28Z","timestamp":1753762228000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between liver function tests abnormalities and type 2 diabetes mellitus patients in Saudi Arabia: a cross-sectional study"],"prefix":"10.3389","volume":"6","author":[{"given":"Nimer","family":"Mehyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad","family":"Alhajeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muath","family":"Alosaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyad","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkarim","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghib","family":"Abusaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-S067","article-title":"Diagnosis and classification of diabetes mellitus","author":"American Diabetes","year":"2013","journal-title":"Diabetes Care"},{"key":"B2","unstructured":"Saudi Arabia 2024"},{"key":"B3","volume-title":"National Diabetes Statistics Report, 2024","year":"2024"},{"key":"B4","article-title":"Global Burden of Disease Study 2021. Results","year":"2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1573399812666160126142605","article-title":"Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions","volume":"13","author":"Robert","year":"2017","journal-title":"Curr. Diabetes Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2021.42.5.20200676","article-title":"Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries","volume":"42","author":"Aljulifi","year":"2021","journal-title":"Saudi Med. J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2174\/1573399820666230731105704","article-title":"Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus in the MENA region: A systematic review","volume":"20","author":"Khalil","year":"2024","journal-title":"Curr. Diabetes Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2016.1168291","article-title":"Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus","volume":"32","author":"Iglay","year":"2016","journal-title":"Curr. Med. Res. Opin"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J. Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18433\/jpps31851","article-title":"Examining liver function in adults with diabetes in the United States","volume":"24","author":"Sakharkar","year":"2021","journal-title":"J. Pharm. Pharm. Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15794","article-title":"Liver disease mortality and hospitalisations among people with type 2 diabetes mellitus: A population-based study","volume":"44","author":"Tomic","year":"2024","journal-title":"Liver Int"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10054-0220","article-title":"Liver function test and diabetes mellitus: correlation from a laboratory perspective","volume":"27","author":"Chilay A","year":"2023","journal-title":"Indian J. Med. Biochem"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S350426","article-title":"Liver enzymes are associated with hyperglycemia in diabetes: A three-year retrospective study","volume":"15","author":"Wan","year":"2022","journal-title":"Diabetes Metab. Synd Ob"},{"key":"B14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.122","article-title":"Regulation of glucose metabolism from a liver-centric perspective","volume":"48","author":"Han","year":"2016","journal-title":"Exp. Mol. Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/87.1.217S","article-title":"Glucose metabolism and hyperglycemia","volume":"87","author":"Giugliano","year":"2008","journal-title":"Am. J. Clin. Nutr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2010.03.028","article-title":"Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats","volume":"186","author":"Palsamy","year":"2010","journal-title":"Chem. Biol. Interact"},{"key":"B18","doi-asserted-by":"publisher","first-page":"494578","DOI":"10.1155\/2015\/494578","article-title":"Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans","volume":"2015","author":"Lucchesi","year":"2015","journal-title":"J. Diabetes Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1078\/0940-2993-00337","article-title":"Ultrastructural, immunohistochemical and biochemical investigations of the rat liver exposed to experimental diabetes und acute hypoxia with and without application of Ginkgo extract","volume":"55","author":"Welt","year":"2004","journal-title":"Exp. Toxicol. Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.17179\/excli2016-800","article-title":"The past and present of serum aminotransferases and the future of liver injury biomarkers","volume":"15","author":"McGill","year":"2016","journal-title":"Excli J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.7.3.248","article-title":"Liver function tests in diabetic patients","volume":"7","author":"Salmela","year":"1984","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws469","article-title":"Liver aminotransferases and risk of incident type 2 diabetes: a systematic review and meta-analysis","volume":"178","author":"Kunutsor","year":"2013","journal-title":"Am. J. Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.12.2913","article-title":"Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men","volume":"28","author":"Wannamethee","year":"2005","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2007.218","article-title":"Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study","volume":"15","author":"Doi","year":"2007","journal-title":"Obes. (Silver Spring)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1036-5","article-title":"Gamma-glutamyltransferase and diabetes\u2013a 4 year follow-up study","volume":"46","author":"Lee","year":"2003","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.1132","article-title":"Drug treatment and type 2 diabetes: the impact of liver disease","volume":"24","author":"Ahmed MH","year":"2007","journal-title":"Pract. Diabetes Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.9270","article-title":"The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial","volume":"13","author":"Razavizade","year":"2013","journal-title":"Hepat Mon"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.11.2029","article-title":"Acarbose-associated hepatotoxicity","volume":"21","author":"Andrade","year":"1998","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000415824.34652.1a","article-title":"LiverTox: clinical and research information on drug-induced liver injury","year":"2012","journal-title":"Bethesda (MD)"},{"key":"B31","volume-title":"A Descriptive Study: The Concept of Gross Domestic Product","author":"Al-Bakr","year":"2016"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6156.1000575","article-title":"Cost of diabetes in the kingdom of Saudi Arabia, 2014","volume":"6","author":"Mokdad","year":"2015","journal-title":"J. Diabetes Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.05.012","article-title":"Characterizing multimorbidity from type 2 diabetes: insights from clustering approaches","volume":"50","author":"Cicek","year":"2021","journal-title":"Endocrinol. Metab. Clin. North Am"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0477-2","article-title":"Comorbidity type and health care costs in type 2 diabetes: A retrospective claims database analysis","volume":"9","author":"Lin","year":"2018","journal-title":"Diabetes Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076388","article-title":"Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study","volume":"384","author":"Kim","year":"2024","journal-title":"BMJ"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000799","article-title":"Fatty liver and cerebrovascular disease: plausible association and possible mechanisms","volume":"33","author":"Khanna","year":"2022","journal-title":"Curr. Opin. Lipidol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"990","DOI":"10.3748\/wjg.v27.i11.990","article-title":"Chronic renal dysfunction in cirrhosis: A new frontier in hepatology","volume":"27","author":"Kumar","year":"2021","journal-title":"World J. Gastroentero"},{"key":"B38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1472-6963-6-84","article-title":"Comorbidity in patients with diabetes mellitus: impact on medical health care utilization","volume":"6","author":"Struijs","year":"2006","journal-title":"BMC Health Serv. Res"},{"key":"B39","volume-title":"The Estimation of Sample Size. Sampling Techniques","author":"Cochran","year":"1963"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14522","article-title":"Association of liver enzymes with incident diabetes in US Hispanic\/Latino adults","volume":"38","author":"Hua","year":"2021","journal-title":"Diabetes Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.899008","article-title":"To explore association between gamma-glutamyl transferase and type 2 diabetes using a real-world study and mendelian randomization analysis","volume":"13","author":"Bi","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1373\/49.8.1358","article-title":"\u03b3-glutamyltransferase is a predictor of incident diabetes and hypertension:: The coronary artery risk development in young adults (CARDIA) study","volume":"49","author":"Lee","year":"2003","journal-title":"Clin. Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1427","article-title":"Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men","volume":"27","author":"Nakanishi","year":"2004","journal-title":"Diabetes Care"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0919","article-title":"Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study","volume":"34","author":"Nguyen","year":"2011","journal-title":"Diabetes Care"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2015-205518","article-title":"Liver enzymes and incident diabetes in China: a prospective analysis of 10\u2013764 participants in the Guangzhou Biobank Cohort Study","volume":"69","author":"Xu","year":"2015","journal-title":"J. Epidemiol. Community Health"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12187","article-title":"Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"30","author":"Schneider","year":"2013","journal-title":"Diabetes Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-022-01905-8","article-title":"Ethnic disparities attributed to the manifestation in and response to type 2 diabetes: insights from metabolomics","volume":"18","author":"Vasishta","year":"2022","journal-title":"Metabolomics"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2015-206050","article-title":"Liver enzymes and incident diabetes in China: a prospective analysis of 10\u2013764 participants in the Guangzhou Biobank Cohort Study","volume":"69","author":"Wannamethee","year":"2015","journal-title":"J. Epidemiol. Community Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018963","article-title":"Combined effect of serum alanine aminotransferase and gamma-glutamyltransferase on incidence of diabetes mellitus: A longitudinal study","volume":"99","author":"Choi","year":"2020","journal-title":"Med. (Baltimore)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.20517\/mtod.2022.20","article-title":"Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk","volume":"2","author":"Lonardo","year":"2022","journal-title":"Metab. Target Organ D"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.5.732","article-title":"Prospective study of serum gamma-glutamyltransferase and risk of NIDDM","volume":"21","author":"Perry","year":"1998","journal-title":"Diabetes Care"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1758","article-title":"Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat","volume":"30","author":"Wallace","year":"2007","journal-title":"Diabetes Care"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S475067","article-title":"Analysis of the association between changes in the GGT\/HDL-C ratio and the risk of diabetes mellitus based on a latent class growth mixed modeling: A longitudinal cohort study of adults in China","volume":"17","author":"Liang","year":"2024","journal-title":"Diabetes Metab. Syndrome Obes"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.13005\/bpj\/487","article-title":"GGT and SGPT - A rising marker in diagnosis of non-alcoholic fatty liver disease","volume":"7","author":"Saxena T","year":"2014","journal-title":"Biomed. Pharmacol. J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01369-x","article-title":"Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study","volume":"20","author":"Fujii","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01906-4","article-title":"Oxidative stress and type 2 diabetes: the development and the pathogenesis, Jordanian cross-sectional study","volume":"29","author":"Abu Khadra","year":"2024","journal-title":"Eur. J. Med. Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/dmrr.196","article-title":"The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society","volume":"17","author":"Rosen","year":"2001","journal-title":"Diabetes Metab. Res. Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010018","article-title":"Oxidative stress, glutathione insufficiency, and inflammatory pathways in type 2 diabetes mellitus: implications for therapeutic interventions","volume":"13","author":"Dawi","year":"2025","journal-title":"Biomedicines"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119126","article-title":"Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells","volume":"99","author":"Matsuoka","year":"1997","journal-title":"J. Clin. Invest"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041509","article-title":"The role of oxidative stress in pancreatic \u03b2 Cell dysfunction in diabetes","volume":"22","author":"Eguchi","year":"2021","journal-title":"Int. J. Mol. Sci"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13010018","article-title":"Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome","volume":"1","author":"Nakagawa","year":"2005","journal-title":"Nat. Clin. Pract. Nephrol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1248614","article-title":"Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus","volume":"14","author":"Gong","year":"2023","journal-title":"Front. Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agl052","article-title":"Age-related changes on serum ggt activity and the assessment of ethanol intake","volume":"41","author":"Puukka","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(92)90206-790206-7","article-title":"Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus","volume":"67","author":"Carmassi","year":"1992","journal-title":"Thromb. Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/JBM.S287136","article-title":"Basic coagulation profiles and platelet parameters among adult type 1 and type 2 diabetes patients at dessie referral hospital, Northeast Ethiopia: comparative cross-sectional study","volume":"12","author":"Ebrahim","year":"2021","journal-title":"J. Blood Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618766254","article-title":"Thrombin generation assay detects moderate-intensity statin-induced reduction of hypercoagulability in diabetes","volume":"24","author":"Park","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112419","article-title":"Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis","volume":"10","author":"Li","year":"2021","journal-title":"J. Clin. Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S349412","article-title":"The prevalence of coagulopathy and associated factors among adult type II diabetes mellitus patients attending the university of gondar comprehensive specialized hospital, Northwest Ethiopia","volume":"15","author":"Getu","year":"2022","journal-title":"Diabetes Metab. Synd Ob"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01372-w","article-title":"Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation","volume":"20","author":"Bryk-Wiazania","year":"2021","journal-title":"Cardiovasc. Diabetol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02366.x","article-title":"Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes","volume":"5","author":"Sauls","year":"2007","journal-title":"J. Thromb. Haemost"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4314\/gmj.v51i3.2","article-title":"High risk of coagulopathy among Type-2 Diabetes Mellitus clients at a municipal hospital in Ghana","volume":"51","author":"Ephraim","year":"2017","journal-title":"Ghana Med. J"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1155\/2004\/797458","article-title":"Disturbances of haemostasis in diabetes mellitus","volume":"19","author":"Fattah","year":"2003","journal-title":"Dis. Markers"},{"key":"B73","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000081919","article-title":"Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications","volume":"14","author":"Erem","year":"2005","journal-title":"Med. Prin Pract"},{"key":"B74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s12872-022-02619-4","article-title":"The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cardiovasc. Disord"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1393137","article-title":"Associations of total protein, albumin, and globulin with insulin resistance: an NHANES study","volume":"15","author":"Zeng","year":"2024","journal-title":"Front. Endocrinol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/0004563215593561","article-title":"Age and sex variation in serum albumin concentration: an observational study","volume":"53","author":"Weaving","year":"2016","journal-title":"Ann. Clin. Biochem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017213","article-title":"Age-related differences in plasma proteins: how plasma proteins change from neonates to adults","volume":"6","author":"Ignjatovic","year":"2011","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13098-019-0409-y","article-title":"Reduced plasma albumin predicts type 2 diabetes and is associated with greater adipose tissue macrophage content and activation","volume":"11","author":"Chang","year":"2019","journal-title":"Diabetol. Metab. Syndr"},{"key":"B79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br. J. Anaesth"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.196","article-title":"Bilirubin metabolism in liver cirrhosis","volume":"52","author":"Ohkubo","year":"1994","journal-title":"Nihon Rinsho"},{"key":"B81","doi-asserted-by":"publisher","first-page":"599","DOI":"10.5009\/gnl20171","article-title":"Direct bilirubin is more valuable than total bilirubin for predicting prognosis in patients with liver cirrhosis","volume":"15","author":"Lee","year":"2021","journal-title":"Gut Liver"},{"key":"B82","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2147\/DMSO.S403483","article-title":"Association of serum bilirubin levels with macro- and microvascular complications in chinese people with type 2 diabetes mellitus: new insight on gender differences","volume":"16","author":"Li","year":"2023","journal-title":"Diabetes Metab. Syndrome Obes"},{"key":"B83","doi-asserted-by":"publisher","first-page":"41338","DOI":"10.1038\/srep41338","article-title":"Serum bilirubin levels and risk of type 2 diabetes: results from two independent cohorts in middle-aged and elderly Chinese","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.01.007","article-title":"The physiology of bilirubin: health and disease equilibrium","volume":"29","author":"Vitek","year":"2023","journal-title":"Trends Mol. Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13098-021-00762-0","article-title":"Associations between serum total bilirubin, obesity and type 2 diabetes","volume":"13","author":"Wei","year":"2021","journal-title":"Diabetol. Metab. Syndr"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s44200-024-00054-8","article-title":"Stable stratified correlation and linear negative correlation between serum albumin and risk of all-cause death in patients with ischaemic stroke","volume":"30","author":"Xu","year":"2024","journal-title":"Artery Res"},{"key":"B87","article-title":"Serum albumin as a predictor of functional outcomes following acute ischemic stroke","volume":"10","author":"Nair","year":"2018","journal-title":"J. Vasc. Interv Neurol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-20924-9","article-title":"Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in diabetes population","volume":"25","author":"Shen","year":"2025","journal-title":"BMC Public Health"},{"key":"B89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12882-023-03110-8","article-title":"The level of serum albumin is associated with renal prognosis and renal function decline in patients with chronic kidney disease","volume":"24","author":"Cheng","year":"2023","journal-title":"BMC Nephrol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2020.35.2.260","article-title":"Recent updates on vascular complications in patients with type 2 diabetes mellitus","volume":"35","author":"Jung","year":"2020","journal-title":"Endocrinol. Metab"},{"key":"B91","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12883-024-03812-y","article-title":"Nutrition-associated markers and outcomes among patients receiving enteral nutrition after ischemic stroke: a retrospective cohort study","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Neurol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S450059","article-title":"Impact of platelet hyperreactivity and diabetes mellitus on ischemic stroke recurrence: A single-center cohort clinical study","volume":"17","author":"Mao","year":"2024","journal-title":"Int. J. Gen. Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1182\/blood.V116.21.4136.4136","article-title":"Elevation of serum free light chains are common in lymphoma and associated with poor event free and overall survival","volume":"116","author":"Maurer","year":"2010","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021786","article-title":"A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas","volume":"144","author":"de Leval","year":"2024","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.207340","article-title":"Serum gamma-glutamyl transferase and risk of heart failure in the community","volume":"30","author":"Dhingra","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302972","article-title":"Serum gamma-glutamyltransferase and the risk of heart failure in men and women in Finland","volume":"99","author":"Wang","year":"2013","journal-title":"Heart"},{"key":"B97","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCHEARTFAILURE.108.826735","article-title":"Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure","volume":"2","author":"Poelzl","year":"2009","journal-title":"Circ. Heart Fail"},{"key":"B98","doi-asserted-by":"publisher","first-page":"481","DOI":"10.21037\/atm.2016.12.27","article-title":"Gamma-glutamyl transferase and cardiovascular disease","volume":"4","author":"Ndrepepa","year":"2016","journal-title":"Ann. Transl. Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02023-y","article-title":"Sodium-glucose cotransporter-2 inhibition for heart failure with preserved ejection fraction and chronic kidney disease with or without type 2 diabetes mellitus: a narrative review","volume":"22","author":"Mentz","year":"2023","journal-title":"Cardiovasc. Diabetol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002680","article-title":"Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices","volume":"9","author":"Nassif","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003166","article-title":"On target: optimum international normalized ratio for left ventricular assist device patients","volume":"9","author":"Connors","year":"2016","journal-title":"Circ. Heart Fail"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.07.021","article-title":"The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease","volume":"55","author":"Oh","year":"2006","journal-title":"Metabolism"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v30.i10.1346","article-title":"Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China","volume":"30","author":"Chen","year":"2024","journal-title":"World J. Gastroenterol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v16.i7.990","article-title":"Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction","volume":"16","author":"Liu","year":"2024","journal-title":"World J. Hepatol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B0720016","article-title":"Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease","volume":"9","author":"Chen","year":"2008","journal-title":"J. Zhejiang Univ Sci. B"},{"key":"B106","doi-asserted-by":"publisher","first-page":"e13022","DOI":"10.7717\/peerj.13022","article-title":"A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study","volume":"10","author":"Wang","year":"2022","journal-title":"PeerJ"},{"key":"B107","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12887-018-1202-z","article-title":"Normal serum alanine aminotransferase and non-alcoholic fatty liver disease among Korean adolescents: a cross-sectional study using data from KNHANES 2010-2015","volume":"18","author":"Kang","year":"2018","journal-title":"BMC Pediatr"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-023-01433-z","article-title":"Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus","volume":"23","author":"Xu","year":"2023","journal-title":"BMC Endocr. Disord"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P099","article-title":"Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease","volume":"44","author":"Cone","year":"2010","journal-title":"Ann. Pharmacother"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-024-01539-1","article-title":"Metformin: past, present, and future","volume":"24","author":"Chaudhary","year":"2024","journal-title":"Curr. Diabetes Rep"},{"key":"B111","article-title":"Metformin for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"99","author":"Farah","year":"2019","journal-title":"Am. Fam Physician"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ24-0168","article-title":"Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease","volume":"71","author":"Xu","year":"2024","journal-title":"Endocr. J"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4128-z","article-title":"Novel pharmacotherapy options for NASH","volume":"61","author":"Ratziu","year":"2016","journal-title":"Dig Dis. Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2018.05.04","article-title":"Liver enzyme trends in patients taking uninterrupted metformin before and after coronary surgery","volume":"8","author":"Nazer","year":"2018","journal-title":"Cardiovasc. Diagn. The"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043056","article-title":"Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis","volume":"7","author":"Kita","year":"2012","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat. Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2016.1185633","article-title":"The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB\/C mice","volume":"54","author":"Saeedi Saravi","year":"2016","journal-title":"Pharm. Biol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1477212","article-title":"Metformin's effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK\/SERCA2b pathway","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00294","article-title":"Role of mitochondria in the mechanism(s) of action of metformin","volume":"10","author":"Vial","year":"2019","journal-title":"Front. Endocrinol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199411030-00006","article-title":"Adverse interaction between warfarin and indomethacin","volume":"11","author":"Day","year":"1994","journal-title":"Drug Safety"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199019020-00006","article-title":"Allopurinol influences aminophenazone elimination","volume":"19","author":"Barry","year":"1990","journal-title":"Clin. Pharmacokinet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1378\/chest.121.1.19","article-title":"Clinical observations with the amiodarone\/warfarin interaction - Dosing relationships with long-term therapy","volume":"121","author":"Sanoski","year":"2002","journal-title":"Chest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.13957","article-title":"Warfarin interactions with antibiotics in the ambulatory care setting","volume":"174","author":"Clark","year":"2014","journal-title":"JAMA Intern. Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13268","article-title":"The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population","volume":"14","author":"Mannheimer","year":"2016","journal-title":"J. Thromb. Haemost"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1984.tb04400.x","article-title":"Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands","volume":"36","author":"Lalloz","year":"1984","journal-title":"J. Pharm. Pharmacol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199606000-00011","article-title":"Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: Presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions","volume":"18","author":"Dasgupta","year":"1996","journal-title":"Ther. Drug Monit"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1617641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T04:10:32Z","timestamp":1753762232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1617641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":126,"alternative-id":["10.3389\/fcdhc.2025.1617641"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2025.1617641","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"article-number":"1617641"}}